The IBA Board of Directors appoints top leaders in the radiopharmaceutical science industry to participate on the IBA Medical Advisory Board.
The IBA Medical Advisory board serves as a liaison between the biomedical research community and the IBA governing body. The members of the Medical Advisory Board actively participate in planning and developing the IBA research initiatives and strategies by making informed recommendations to the IBA Board of Directors and other appropriate IBA officials.
Jean-François Chatal, Ph.D., M.D.
Professor of Nuclear Medicine ,
INSERM-University Research Unit, Nantes, France
Peter S. Conti, Ph.D., M.D. (not pictured)
Professor of Radiology, Biomedical Engineering and Pharmacy, University of Southern California
Director, PET Imaging Science Center, University of Southern California
Chaitanya R. Divgi, M.D.
Professor of Radiology, University of Pennsylvania
Chief, Division of Nuclear Medicine & Clinical Molecular Imaging
William C. Eckelman, Ph.D.
President, Molecular Tracer LLC
Chair, Scientific Advisory Committee, Molecular Insight Pharmaceuticals
Adjunct Professor, University of California, San Diego
Peter J. Ell, M.D. (not pictured)
Chair, Nuclear Medicine, University of London
Director, Institute of Nuclear Medicine, University College London
Fellow, Academy of Medical Sciences, London
Max Lonneux,Ph.D., M.D
Nuclear Medicine Department
University Clinic Saint-Luc, Brussels, Belgium
Mathew Thakur, Ph.D.
Professor, Radiology & Radiation Oncology, Thomas Jefferson University Medical College
Director, Radiopharmaceutical Research, Thomas Jefferson University Medical College
Michael R. Zalutsky
Professor, Radiology and Biomedical Engineering, Duke University
Director, Radiolabeling Shared Resource, Duke University Medical Center Comprehensive Cancer Center
Co-Director, Cancer Immunobiology Program, Duke University Medical Center Comprehensive Cancer Center